dostarlimab
gsk
['dostarlimab', 'rectal']
'unprecedented' 100% of first 14 untreated patients with rectal cancer respond to pd-1 blocker dostarlimab-gxly - the asco post 
Molecular pathologist & cancer scientist: focus on clinical cancer genomics, targeted therapies, sarcomas, lung cancer, mesothelioma @sloan_kettering